Obstetrical and perinatal outcomes in fetuses with early versus late sonographic diagnosis of short femur length: A single-center, prospective, cohort study.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 03 05 2020
revised: 14 09 2020
accepted: 14 09 2020
pubmed: 30 9 2020
medline: 15 5 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

The aim of this study was to evaluate obstetrical and perinatal outcomes in fetuses with short femur length diagnosed before or after 24 weeks of gestation. This was a prospective cohort study on singleton pregnancies with a diagnosis of fetal femur < 5 centile. Included patients were divided into two groups: patients with a first diagnosis of femur length < 5th percentile at 14-24 weeks (group A) and those with the first diagnosis made at > 24 weeks (group B). 147 patients were included for the analysis. Group A and group B included 66 (44.9%) and 81 (55.1%) cases. Abnormal fetal karyotype and skeletal dysplasia rates were significantly higher (27.3% vs 3.7%,P < 0.001 and 19.7% vs 3.7%, P = 0.002) in group A. Women in group B had a higher incidence of small for gestational age and intrauterine growth restriction (7.6% vs 24.7%, P = 0.007 and 19.7% vs 44.4%, P = 0.002). There was a significant higher incidence of live births in group B (34.9% vs 97.5%, P < 0.001), while the rate of termination of pregnancy was increased in group A (56.1% vs 1.2%, P < 0.001). No significant difference was found in perinatal outcomes of live births, when comparing group A and B. The incidence of abnormal karyotype and skeletal dysplasia is higher when short femur length diagnosed earlier in gestation, while the incidence of small for gestational age, intrauterine growth restriction and the rate of live births are significantly increased when short femur length is diagnosed later during pregnancy.

Identifiants

pubmed: 32992237
pii: S0301-2115(20)30603-5
doi: 10.1016/j.ejogrb.2020.09.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

170-174

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Valentina D'Ambrosio (V)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy. Electronic address: dr.valentina.dambrosio@gmail.com.

Flaminia Vena (F)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Chiara Boccherini (C)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Daniele Di Mascio (D)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Antonia Squarcella (A)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy; Department of Experimental Medicine, Sapienza University of Rome, Italy.

Sara Corno (S)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Cristina Pajno (C)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Antonio Pizzuti (A)

Department of Experimental Medicine, Sapienza University of Rome, Italy.

Maria Grazia Piccioni (MG)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Roberto Brunelli (R)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Antonella Giancotti (A)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH